Biopsy

Understand

Overview

A biopsy is a diagnostic procedure that removes a small fragment of tissue or a group of cells from a suspicious lesion for examination under a microscope by a pathologist. Unlike imaging tests, which show only the shape, size, and structure of a lesion, a biopsy provides information about its actual cellular makeup — it answers whether a lesion is benign, malignant, inflammatory, or infectious, and is the only method that gives a definitive, conclusive histopathological diagnosis in the vast majority of cancers and many diseases of solid organs.

The clinical significance of a biopsy goes far beyond simply confirming or ruling out a malignancy. Tissue material allows the histological subtype of a lesion to be determined, its degree of differentiation (grade), and — thanks to immunohistochemical and molecular techniques — also its receptor and genetic profile, which today directly determines the choice of targeted therapy, for example in breast, lung, or lymphoid cancers. No imaging test, however advanced, can provide this level of information — imaging shows where a lesion is and how large it is, while a biopsy answers what that lesion actually is at the cellular level.

Biopsies are ordered in very different clinical contexts. Most commonly it's a suspicious focal lesion found on imaging — a lump in the breast, lung, thyroid, or a lymph node — requiring a histopathological answer before treatment decisions can be made. A second large group of indications is abnormal lab results suggesting disease of a specific organ — chronically elevated liver enzymes unexplained by non-invasive workup, abnormal blood counts suggesting bone marrow disease, or an elevated PSA level after an inconclusive prostate MRI. A third group is skin lesions raising suspicion of melanoma or another skin cancer, where a biopsy is often both a diagnostic procedure and the first step of treatment.

On the practical side, most biopsies are outpatient procedures performed under local anesthesia, lasting anywhere from a few minutes to about an hour, after which the patient usually goes home the same day. Preparation depends on the technique and location — most often it involves stopping anticoagulant and antiplatelet medications a few days before the procedure after consulting the treating physician, and for some procedures (e.g., biopsies of abdominal organs), fasting. The collected material goes to a pathology lab, where it undergoes fixation, paraffin embedding, sectioning, and staining — a standard result is usually available after a few days, while additional testing (immunohistochemistry, molecular tests) can extend the wait to two or three weeks.

A number of misconceptions have grown up around biopsies that are worth dispelling. Some patients worry that puncturing a tumor spreads cancer cells throughout the body — the risk of this phenomenon (so-called needle-tract seeding) is very low with modern coaxial techniques and, based on available data, doesn't meaningfully worsen prognosis in the vast majority of clinical situations. Another misconception is the belief that a normal imaging result makes a biopsy unnecessary — imaging and histopathology answer entirely different questions and in many situations are complementary rather than interchangeable.

The choice of a specific biopsy technique depends on the location of the lesion, its accessibility, size, and the clinical question the result needs to answer — from a thin aspiration needle collecting individual cells, through a thicker core needle preserving tissue architecture, to a surgical procedure removing all or part of a lesion. Biopsies are increasingly performed under imaging guidance (ultrasound, CT, mammographic stereotaxis), which allows even non-palpable, deep-seated lesions to be precisely targeted.

Biopsy remains the gold standard of histopathological diagnosis and the starting point for most oncology decisions, despite the rapid development of non-invasive alternatives such as liquid biopsy or advanced imaging. Its value lies not only in confirming the presence of disease, but above all in precisely characterizing its biology — information without which modern, personalized cancer treatment simply wouldn't be possible.